Experience and Expertise: Other

Webinars & Industry Presentations

Other Areas of Experience and Expertise

Nephrology Transplant Rejection
  • Assessment of novel metallomatrix pathway-targeting agent for diabetic neuropathy
  • Evaluation and forecasting of drug delivery play on erythropoietin
  • Assessment of novel MOA for ESRD
  • Opportunity search for development products within the renal space
  • Evaluation and forecasting of next generation calcineurin inhibitors with improved tolerability proposition
  • Evaluation of novel, tolerizing biologicals for transplant and other immune settings
  • Evaluation of targeted anti-lymphocyte cell surface-targeting monoclonal for SCT and SOT
Urology Women’s Health
  • Scientific and commercial assessment of a novel biologic therapy for superficial bladder cancer
  • Development of an in-licensing/acquisition strategy for a nascent urology franchise
  • Critical evaluation of clinical development and market positioning strategies for a first-in-class therapy (benign prostatic hyperplasia and hypogonadism)
  • Assessment of future market for female sexual dysfunction, including forecast for several pipeline agents
  • Evaluation of novel MOA for the treatment of vasomotor symptoms
  • Detailed evaluation of urinary incontinence/overactive bladder market and revenue potential for a niche market opportunity


Ophthalmology Dermatology
  • Assessment, partner identification, and sales force estimates for cell based therapy for corneal surface disorders
  • Evaluation and forecast of next generation anti-VEGF therapies for wet AMD (several projects)
  • Market landscape and pipeline evaluations for major ophthalmology segments of glaucoma, retinal disease, and dry eye
  • Evaluation & forecast of next generation cosmetic fillers and botulinum toxin products
  • Evaluation & forecast for topical products aimed at treating actinic keratoses and cutaneous warts
  • Search projects aimed at identifying potential “corner property” acquisitions for dermatology including evaluation of typical products for acne, psoriasis, and other common dermatology indications
Orphan’s Diseases Gastroenterology
  • Market assessments for expanded indications of marketed injectable product for spasticity, and other orphan indications
  • Detailed competitive analysis & recommendations for next generation approaches in blood diseases such as hemophilia, ITP, & myelodysplastic syndromes
  • Opportunity searches for potential in-licensing and acquisition targets for orphan metabolic diseases, cystic fibrosis, and pulmonary hypertension


  • Evaluation and forecasting of products for post-operative ileus, inflammatory bowel disease (biologicals/small molecules), and ‘topical’ steroids
  • Analysis of the pancreatic enzyme market and recommendation of a competitive positioning
  • Assisted a biotechnology company with identification and prioritization of potential in-licensing opportunities focused on indications in the GI specialty setting